// App-Quantinova.ai

: The Impact of Trastuzumab on the Pulmonary Artery Systolic Pressure in Patients With HER-2 Positive Breast Cancer

Researchers

Presenter

  • Zaid A Abdulelah

Principal Investigators

  • Mohammad Z Khrais

  • Ruba A Ghalayni

  • Faris Al-Khalili

  • Mohammad Alqaisieh

  • Mu'taz F AbuAlSha'r

  • Ahmed A Abdulelah

  • Yazan S Abandeh

  • Dalia Al-Rimawi

  • Ismail R Hamam

Medical Centers

  • Cardiology, King Hussein Cancer Cntr, Amman, Jordan

  • Sch of Medicine, The Univ of Jordan, Amman, Jordan, Amman, Jordan

  • Department of Internal Medicine , King Hussein Cancer Center, Amman, Jordan

  • Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan

  • Cardiology, St Bartholomew's Hosp, London, United Kingdom

  • Mayo Clinic, Rochester, MN

  • King Hussein Cancer Center, Amman, Jordan

Locations

  • Jordan

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Carboxypeptidase B1

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved